Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel P2Y12 Inhibitors”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableEnded earlyNCT02030548
What this trial is testing

Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome
Medical University of Graz 144
Post-approval studies (Phase 4)UnknownNCT02028234
What this trial is testing

"Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 150
Post-approval studies (Phase 4)Study completedNCT02049762
What this trial is testing

Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy

Who this might be right for
Acute Coronary SyndromePlatelet Function and Reactivity TestsNovel P2Y12 Inhibitors
Sheba Medical Center 29
Post-approval studies (Phase 4)Study completedNCT02545933
What this trial is testing

Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor

Who this might be right for
Myocardial Infarction
University of Florida 130
Post-approval studies (Phase 4)UnknownNCT02030054
What this trial is testing

Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 150